What is PharPoint Research?
PharPoint Research is a privately owned contract research organization (CRO) based in the US. The company specializes in providing agile and comprehensive drug development solutions tailored to clients across various scales, from emerging biotechs to established pharmaceutical firms. Its expertise spans the critical phases of bringing new therapies to market, offering a vital service within the life sciences ecosystem.
How much funding has PharPoint Research raised?
PharPoint Research has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in PharPoint Research
PPP
Public-Private Partnership
What's next for PharPoint Research?
The recent major enterprise-level funding and strategic investment indicate a period of accelerated growth and expansion for PharPoint Research. This influx of capital is likely to fuel advancements in its service offerings, potentially enabling the company to broaden its client base, invest in cutting-edge research technologies, and enhance its operational capacity. The strategic nature of the investment suggests a focus on strengthening market presence and solidifying its competitive advantage in the CRO landscape.
See full PharPoint Research company page
